HALO logo
halo search icon
Nyxoah SA
Nyxoah SA
NYXH · NAS

Nyxoah SA

US$2.86

Price Arrow0.05 (1.78%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusBig CandleHALO AllHALO Balance SheetHALO Capital EfficiencyHALO Consensus ValueHALO Earnings Momentum+4
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Nyxoah SA Overview

NYXH Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Strong

Growth

Earnings

Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About NYXH

icon

Website

Nyxoah SA

icon

Telephone

32.10.22.23.55

icon

Address

Rue Edouard Belin 12, Mont-Saint-Guibert, Walloon Region 1435

Description

Nyxoah SA is a medical technology company, which engages in the development and commercialization of solutions to treat Obstructive Sleep Apnea (OSA). Its solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe OSA. The company was founded by Robert Taub and Adi Mashiach on July 15, 2009, and is headquartered in Mont-Saint-Guibert, Belgium.

NYXH Price Chart

Key Stats

Market Cap

US$120.51M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 2.72 - 8.64

Trade Value (12mth)

US$87,933.00

1 week

-8.77%

1 month

-12.73%

YTD

-37.56%

1 year

-65.09%

All time high

37.00

Key Fundamentals

EPS 3 yr Growth

109.90%

EBITDA Margin

-801.10%

Operating Cashflow

-$76m

Free Cash Flow Return

-69.60%

ROIC

-92.90%

Interest Coverage

-16.20

Quick Ratio

1.10

Other Data

Shares Outstanding (Fully Diluted)

43m

HALO Sector

Healthcare

Next Company Report Date

25-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

NYXH Announcements

Latest Announcements

DateAnnouncements
13 May 26
27 March 26
31 January 26
15 January 26
20 December 25

NYXH Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-1.67-1.96-2.67locklocklock
EPS (Fully Diluted)
$locklocklocklock-1.67-1.96-2.67locklocklock
Growth
%locklocklocklock-31.4-17.2-36.3locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Nyxoah SA (NYXH:NAS)?
Halo FAQ
The current share price of Nyxoah SA (NYXH:NAS) is USD$2.86.
What is the 52-week high share price for Nyxoah SA (NYXH:NAS)?
Halo FAQ
The 52-week high share price for Nyxoah SA (NYXH:NAS) is USD$8.64.
What is the 52-week low share price for Nyxoah SA (NYXH:NAS)?
Halo FAQ
The 52-week low share price for Nyxoah SA (NYXH:NAS) is USD$2.72.
What is the dividend yield for Nyxoah SA (NYXH:NAS)?
Halo FAQ
Nyxoah SA (NYXH:NAS) does not pay a dividend.
What was Nyxoah SA (NYXH:NAS) last dividend payment?
Halo FAQ
Nyxoah SA (NYXH:NAS) does not pay a dividend.
What is the franking level for Nyxoah SA (NYXH:NAS)?
Halo FAQ
Nyxoah SA (NYXH:NAS) has a franking level of 0.00%.
In which sector is Nyxoah SA (NYXH:NAS) classified?
Halo FAQ
Nyxoah SA (NYXH:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.